Psychiatric NP Scope of Practice for ADHD in Pennsylvania

You’ve built a successful psychiatric practice treating ADHD, but you’re wondering: can you prescribe Adderall or Ritalin through telehealth without seeing patients in person? With federal rules extended through 2026 and state laws all over the map, it’s a legitimate question — and one that could make or break your decision to join a telehealth platform.

Here’s the reality: Yes, you can prescribe Schedule II ADHD medications via telehealth in 2026, but the rules depend on where your patient is located, what your license allows, and whether you’re prepared for what’s coming in 2027. Let’s cut through the regulatory confusion so you can make confident decisions about your practice.

Federal Law: What You Can Do Right Now (Through December 31, 2026)

The Ryan Haight Act normally requires an in-person medical evaluation before prescribing any controlled substance. That rule would’ve killed telehealth ADHD care before it started — except COVID changed everything.

In March 2020, the DEA waived the in-person requirement for Schedule II-V controlled substances prescribed via telehealth. That flexibility has been extended four times, most recently through December 31, 2026. This means right now, you can:

• Conduct a video evaluation with a new ADHD patient
• Prescribe stimulants (Adderall, Vyvanse, Ritalin, etc.) without any prior in-person visit
• Continue managing patients entirely via telehealth

The catch? This is temporary. The DEA is finalizing permanent telemedicine rules that will likely require a special registration and additional safeguards (like mandatory nationwide PDMP checks and enhanced patient identity verification) starting in 2027.

What’s Coming: DEA’s Permanent Rules

The DEA announced in January 2025 that three new telemedicine rules are in the works. Here’s what matters for ADHD prescribers:

Telemedicine Special Registration: You’ll be able to obtain a DEA telemedicine registration that authorizes prescribing controlled substances without an in-person exam. This registration will require:

• Mandatory PDMP database checks (the DEA is building a national hub)
• Strict patient identity verification during video consults
• Compliance with new platform registration rules (telehealth companies themselves will need DEA oversight)

Established Patient Exception: If you’ve seen a patient in person at least once (or another provider in your practice has), these new rules won’t apply. You can continue telehealth follow-ups without jumping through extra hoops.

The Bottom Line: Plan to obtain the special registration in 2027 if you want to continue seeing new ADHD patients via telehealth. It’s a bureaucratic hurdle, but it beats the alternative (mandatory in-person visits for all new patients).

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Rules: Where It Gets Complicated

Federal law sets the floor — but your state sets the ceiling. Here’s what you need to know for the six states with the highest demand for telehealth ADHD care.

California: Telehealth-Friendly, NPs Gaining Independence

Can you prescribe ADHD meds via telehealth? Yes. California explicitly allows telehealth evaluations to satisfy the ‘appropriate prior examination’ requirement for prescribing. No in-person visit needed.

Scope of Practice:

• Psychiatrists (MD/DO): Full prescribing authority. No restrictions beyond federal law.
• PMHNPs: Transitioning to full practice authority through 2026. Experienced NPs (3+ years or 4,600 hours under physician oversight) can practice and prescribe independently. New grads still need supervising physicians initially.

Key Requirements:

• Check the CURES PDMP before the initial prescription and at least every 4 months for ongoing Schedule II therapy (mandatory)
• Use electronic prescribing
• Must hold a California license (no compact or telehealth registration shortcut)

Why California Works: The regulatory environment is clear, NPs are moving toward independence, and the market is massive. The main barrier is getting licensed — California isn’t in the Interstate Medical Licensure Compact, so out-of-state physicians face a lengthy application process.

Texas: Physicians Only for Stimulants

Can you prescribe ADHD meds via telehealth? Physicians can. Nurse practitioners cannot.

The Big Restriction: Texas law prohibits APRNs and PAs from prescribing Schedule II controlled substances in outpatient settings. Period. The only exceptions are hospital inpatients (≥24 hours), hospice patients, or emergency department orders.

What This Means:

• Psychiatrists (MD/DO): You’re good to go. Treat ADHD patients via telehealth, prescribe stimulants, no special state restrictions beyond federal rules.
• PMHNPs: You can evaluate and diagnose ADHD, but a physician must write the prescription. You’ll need a collaborating psychiatrist on every stimulant case.

Key Requirements:

• Use the Texas PDMP (recommended for stimulants, though only mandated for opioids/benzos)
• Electronic prescribing is mandatory for all controlled substances
• Must hold a Texas medical license (physicians can use IMLC to expedite)

Why Texas Is Hard: The NP prescribing restriction means you can’t staff a Texas telehealth practice with nurse practitioners alone. You need psychiatrists, and they’re in short supply. For platforms like Klarity, this means either recruiting Texas-licensed MDs or pairing NPs with physician oversight — which adds cost and complexity.

Florida: Clear Exception for Psychiatric Disorders

Can you prescribe ADHD meds via telehealth? Yes — Florida statute explicitly permits it.

Florida law generally bans telehealth prescribing of Schedule II controlled substances, except for treatment of psychiatric disorders, inpatient care, hospice, or nursing home residents. ADHD qualifies as a psychiatric disorder, so you’re covered.

Scope of Practice:

• Psychiatrists (MD/DO): Full authority. Can use Florida’s out-of-state telehealth registration if you don’t have a FL license (unique advantage).
• PMHNPs: Can prescribe stimulants without the general 7-day Schedule II supply limit (that limit doesn’t apply to psychiatric nurses treating mental disorders). However, you must work under a protocol agreement with a supervising psychiatrist — Florida didn’t include psych NPs in its independent practice law.

Key Requirements:

• Check the E-FORCSE PDMP before prescribing controlled substances for patients ≥16
• Document that treatment falls under the ‘psychiatric disorder’ exception
• Out-of-state providers can register for a Florida telehealth credential (doesn’t require full licensure, but you still need DEA registration covering Florida)

Why Florida Works: The statutory carve-out removes ambiguity. You’re not interpreting whether telehealth prescribing is ‘allowed’ — it’s explicitly authorized for ADHD. The out-of-state registration option is a bonus for multi-state practices.

New York: Recently Updated to Align with Federal Law

Can you prescribe ADHD meds via telehealth? Yes, as of May 2025.

New York updated its controlled substance prescribing regulations in May 2025 to explicitly allow telehealth prescribing when consistent with federal DEA rules. Translation: as long as the federal waiver is active (through 2026), you’re good. When DEA’s permanent rules kick in, New York will require compliance with those.

Scope of Practice:

• Psychiatrists (MD/DO): Full authority.
• PMHNPs: After 3,600 hours of experience, NPs can practice independently without a written collaborative agreement. They can prescribe stimulants up to a 90-day supply (unique to NY — use prescription code ‘B’ for ADHD to authorize the 90-day supply).

Key Requirements:

• Check the I-STOP PMP registry before every Schedule II stimulant prescription (mandatory and heavily enforced)
• Electronic prescribing required for all controlled substances (since 2016)
• Need a New York controlled substance license number from the Bureau of Narcotic Enforcement (in addition to DEA registration)

Why New York Works: The May 2025 regulatory update removed legal uncertainty. NPs gain independence relatively quickly (compared to other states), and the 90-day prescription option is a practice efficiency win for stable patients. The downside? New York isn’t in the IMLC, so out-of-state physicians need a full license.

Pennsylvania: NPs Limited to 30-Day Supplies

Can you prescribe ADHD meds via telehealth? Yes. Pennsylvania has no state prohibition beyond federal law.

Scope of Practice:

• Psychiatrists (MD/DO): Full authority. Pennsylvania is in the IMLC, so out-of-state physicians can expedite licensure.
• CRNPs: Must have a collaborative agreement with a physician. Limited to 30-day supplies of Schedule II controlled substances. Any refill beyond 30 days requires physician approval (not a co-signature, but consultation/approval from the collaborating doctor).

Key Requirements:

• Check the PA PDMP before the initial prescription in a new course of treatment (and periodically thereafter)
• Electronic prescribing mandatory for controlled substances (since 2019)
• Must hold a Pennsylvania license (no special telehealth registration)

Why Pennsylvania Is Moderate: The 30-day limit on NP prescribing adds administrative overhead (monthly physician touchpoints), but it’s workable. The IMLC membership helps recruit out-of-state psychiatrists. The main gap is Pennsylvania’s lack of a formal telehealth statute — practice is governed by board policy, which could theoretically change.

Illinois: Two-Tier System for NPs

Can you prescribe ADHD meds via telehealth? Yes.

Scope of Practice (NPs): Illinois has a Full Practice Authority pathway for APRNs who complete 4,000 hours of practice and 250 hours of continuing education. This creates two tiers:

Tier 1 — Collaborative Practice (No FPA):

• NP must have a written collaborative agreement with a physician
• Limited to 30-day supplies of Schedule II (stimulants)
• Any continuation beyond 30 days requires physician approval
• Physician must review the NP’s Schedule II prescribing monthly

Tier 2 — Full Practice Authority:

• NP can prescribe stimulants independently, without physician collaboration or approval
• No 30-day limit
• Important: The Illinois rule requiring physician consultation for Schedule II narcotics and benzos does not apply to stimulants (they’re non-narcotic Schedule II)

Key Requirements:

• Must have an Illinois controlled substance license (in addition to professional license and DEA registration)
• PDMP checks recommended (mandatory for opioids/benzos, advisable for stimulants)
• Must hold an Illinois license

Why Illinois Works: The FPA pathway means experienced NPs can operate with full autonomy — huge for scaling a telehealth practice. New NPs need physician oversight, but the 30-day rule is similar to Pennsylvania. Illinois also has strong telehealth parity laws (including Medicaid mandates for tele-mental health), so the regulatory environment is favorable.

State Comparison: The Tl;dr

What About Patient Acquisition Cost?

Here’s where most telehealth advice goes off the rails. You’ll read articles claiming you can acquire ADHD patients for ‘$30-50 per lead’ through Google Ads or SEO. That’s fantasy.

Reality check on DIY marketing:

• Google Ads: Mental health keywords cost $15-40+ per click. Most clicks don’t convert. A realistic cost per booked patient (not just a click) through PPC is $200-400+, once you factor in wasted spend, no-shows, and the time your staff spends qualifying leads.
• SEO: Takes 6-12 months of consistent investment (content, backlinks, technical optimization) before generating meaningful patient flow. Most solo providers don’t have the expertise, budget, or patience.
• Directory listings: Psychology Today, Zocdoc, etc., charge monthly fees and you compete with hundreds of other providers. Zocdoc charges $35-100+ per booking, plus the monthly subscription. Total monthly cost for a meaningful patient volume? Easily $500-1,000+.
• All-in cost: When you add up agency/consultant fees, ad spend testing, staff time handling leads, no-shows from cold traffic, and months of investment before results — acquiring a qualified psychiatric patient through DIY channels typically costs $200-500+.

The Klarity Model: Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay a standard listing fee per new patient lead. That’s it. No upfront marketing spend, no monthly subscriptions, no wasted ad budget on clicks that don’t convert.

• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

This is guaranteed ROI versus gambling on marketing channels. For most providers — especially those starting out, adding a new revenue stream, or scaling — a platform that handles patient acquisition entirely removes the risk.

What This Means for Your Practice

If you’re a psychiatrist, the path is straightforward: get licensed in your target states (prioritize those with IMLC if you’re not already licensed), obtain DEA registration covering those states, and prepare for the DEA’s special registration requirement in 2027. You can treat ADHD patients via telehealth in all 50 states (with the understanding that you follow each state’s PDMP and e-prescribing rules).

If you’re a psychiatric nurse practitioner, your calculus is state-dependent:

• Best opportunities: California (moving to FPA), New York (3,600-hour independence), Illinois (FPA after 4,000 hours)
• Moderate: Pennsylvania and Florida (collaborative agreements required, but stimulant prescribing allowed)
• Dead end: Texas (unless you’re paired with a physician who writes all stimulant prescriptions)

For platforms like Klarity, this state-by-state variation is exactly why we handle credentialing, regulatory compliance, and patient matching. You focus on clinical care; we handle the rest.

The 2027 Question: What Happens When the Waiver Ends?

The federal extension runs through December 31, 2026. In 2027, one of two things happens:

Scenario 1 (Likely): The DEA finalizes its permanent telemedicine rules. You obtain the special registration, comply with the new PDMP and identity verification requirements, and continue prescribing ADHD meds via telehealth without interruption.

Scenario 2 (Unlikely but Possible): The DEA reverts to strict Ryan Haight enforcement, requiring an in-person exam before prescribing any controlled substance. Telehealth ADHD care essentially ends (or becomes hybrid, requiring initial in-office visits).

The DEA has signaled that Scenario 1 is the plan — they’ve been clear about preserving telehealth access while adding safeguards. But until the final rules are published, there’s uncertainty.

What you should do now:

1. Build your telehealth practice under current rules (you have through 2026)
2. Stay informed on DEA rule updates (we’ll keep Klarity providers updated)
3. Prepare to obtain the special registration in 2027 (it’s a compliance step, not a barrier)

The regulatory landscape for ADHD telemedicine is more stable than it’s ever been — and far more favorable than most providers realize. You just need to know the rules.

Ready to Treat ADHD Patients via Telehealth?

Klarity Health connects psychiatrists and PMHNPs with pre-qualified ADHD patients across all 50 states. We handle licensing support, credentialing, patient acquisition, and platform infrastructure. You control your schedule and only pay when you see patients.

Learn more about joining Klarity’s provider network and start seeing ADHD patients this month — without spending a dollar on marketing or worrying about compliance.

Frequently Asked Questions

Can I prescribe Adderall via telehealth without ever meeting the patient in person?
Yes, through December 31, 2026, under the federal DEA extension. After that, you’ll likely need a DEA telemedicine special registration, but in-person visits won’t be required if you meet the new safeguards (PDMP checks, identity verification). This applies in all 50 states, though your state license and scope of practice still govern what you can prescribe.

Do nurse practitioners have the same prescribing authority as psychiatrists for ADHD medications?
It depends on the state. In California, New York, and Illinois (with Full Practice Authority), experienced PMHNPs can prescribe stimulants independently. In Pennsylvania and Florida, NPs need collaborative agreements with physicians. In Texas, NPs cannot prescribe Schedule II stimulants in outpatient settings at all — only physicians can.

What’s the difference between treating ADHD via telehealth in Florida vs. Texas?
Florida explicitly allows telehealth prescribing of Schedule II stimulants for ‘psychiatric disorders’ (including ADHD), so both psychiatrists and PMHNPs (under physician protocol) can prescribe. Texas allows psychiatrists to prescribe via telehealth but prohibits nurse practitioners from prescribing any Schedule II controlled substances in outpatient settings. If you’re a PMHNP, you can practice telehealth ADHD care in Florida; in Texas, you’d need a physician to handle all prescriptions.

How much does it cost to acquire an ADHD patient through traditional marketing?
Realistically, $200-500+ per qualified, booked patient when you factor in all costs. Google Ads for mental health keywords run $15-40+ per click, and most clicks don’t convert to appointments. SEO takes 6-12 months and thousands of dollars before generating results. Directory listings (Psychology Today, Zocdoc) charge monthly fees plus per-booking fees. Most solo providers underestimate the true cost because they don’t account for wasted ad spend, staff time qualifying leads, no-shows, and months of investment before ROI. A pay-per-appointment model eliminates all that risk.

Will I need to see ADHD patients in person eventually, or can I manage them entirely via telehealth?
Under current rules (through 2026), you can manage ADHD patients entirely via telehealth — no in-person visit required at any point. Starting in 2027, the DEA’s new rules will likely allow ongoing telehealth-only care if you have the special telemedicine registration. Some states have no in-person follow-up requirements; others defer to clinical judgment. As long as the standard of care is met via video, most states don’t mandate periodic in-person visits for stable ADHD patients.

What happens if the DEA doesn’t finalize the permanent rules by January 2027?
The DEA has extended the flexibility four times to avoid exactly this scenario. They’ve publicly committed to finalizing rules before the December 2026 deadline. If they don’t, there are three options: another extension (which they’ve done repeatedly), emergency rulemaking to maintain flexibilities, or reversion to strict Ryan Haight enforcement (requiring in-person exams). Given the political and practical realities — millions of patients now depend on telehealth ADHD care — most legal experts expect the DEA will ensure continuity, either through timely final rules or another extension.

Sources and References

The following sources were consulted to ensure accuracy and timeliness of the regulatory information in this guide. All details reflect current laws and rules as of February 2026.

1. DEA & HHS Press Release – Extension of Telemedicine Flexibilities Through 2026 (January 2, 2026)
   https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
   Official announcement of the fourth extension of telehealth controlled substance prescribing flexibility through December 31, 2026.

2. Healthcare Dive – DEA, HHS extend telehealth controlled substance prescribing flexibilities for fourth time (January 5, 2026)
   https://www.healthcaredive.com/news/dea-hhs-extend-telehealth-controlled-substance-prescriptions-flexibilities-fourth-time/808735/
   Industry analysis of the 2026 DEA extension, including scope and timeline details.

3. DEA Press Release – DEA Announces Three New Telemedicine Rules to Continue Open Access (January 16, 2025)
   https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access
   Official DEA summary of proposed permanent telemedicine regulations, including special registration and PDMP requirements.

4. RxAgent Blog – Nurse Practitioner Prescriptive Authority by State (2026 Guide) (December 28, 2025)
   https://rxagent.co/blog/np-prescribing-authority
   Comprehensive state-by-state analysis of NP scope of practice and prescribing authority, with statutory references.

5. Texas Board of Nursing – APRN Practice FAQ: Prescriptive Authority
   https://www.bon.texas.gov/faqpracticeaprn.asp.html
   Official guidance confirming Texas APRNs cannot prescribe Schedule II controlled substances in outpatient settings (exceptions limited to hospital/hospice).

6. Florida Statutes Section 456.47 – Telehealth
   http://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html
   Primary Florida law establishing the psychiatric disorder exception for Schedule II telehealth prescribing.

7. Florida Statutes Section 464.012 – Certification of Advanced Practice Registered Nurses
   http://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&StatuteYear=2017&URL=0400-0499/0464/Sections/0464.012.html
   Florida law on APRN prescribing authority, including the 7-day Schedule II limit and psychiatric nurse exception.

8. New York State Department of Health – Guidance on Prescribing Controlled Substances via Telehealth (May 21, 2025)
   https://www.ninthdistrict.org/home/2025/05/30/nysdoh-issues-guidance-on-prescribing-controlled-substances-via-telehealth
   Official NYSDOH guidance aligning state controlled substance prescribing rules with federal telehealth allowances (effective May 2025).

9. Pennsylvania Code Title 49, Chapter 21 – State Board of Nursing: Certified Registered Nurse Practitioners
   https://www.pacodeandbulletin.gov/secure/pacode/data/049/chapter21/chap21toc.html
   Pennsylvania administrative code establishing the 30-day Schedule II prescribing limit for CRNPs.

10. Illinois Administrative Code Title 68, Part 1300 – Nursing Practice Act Rules
    https://www.ilga.gov/agencies/JCAR/EntirePart?titlepart=06801300
    Illinois regulations governing APRN prescriptive authority, collaboration requirements, and Full Practice Authority criteria.

11. Center for Connected Health Policy – State Telehealth Laws: Online Prescribing
    https://www.cchpca.org/topic/online-prescribing/
    Policy analysis and state law aggregation on telehealth prescribing requirements (updated January 2026).

All regulatory details have been cross-verified with official state statutes, medical board rules, and federal agency publications to ensure accuracy as of February 2026.

Source:

• https://www.healthcaredive.com/news/dea-hhs-extend-telehealth-controlled-substance-prescriptions-flexibilities-fourth-time/808735/#:~:text=,II%20to%20Schedule%20V%20drugs
• https://www.healthcaredive.com/news/dea-hhs-extend-telehealth-controlled-substance-prescriptions-flexibilities-fourth-time/808735/#:~:text=,to%20hash%20out%20permanent%20regulations
• https://rxagent.co/blog/np-prescribing-authority#:~:text=Proposed%20DEA%20rules%20create%20a,for%20telemedicine%20prescribing
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=there%20any%20settings%20other%20than,may%20prescribe%20Schedule%20II%20controlled
• https://www.ninthdistrict.org/home/2025/05/30/nysdoh-issues-guidance-on-prescribing-controlled-substances-via-telehealth#:~:text=as%20such%20terms%20are%20defined,the%20use%20of%20electronic%20prescribing
• https://www.pacodeandbulletin.gov/secure/pacode/data/049/chapter21/chap21toc.html#:~:text=,
• https://www.ilga.gov/agencies/JCAR/EntirePart?titlepart=06801300#:~:text=match%20at%20L5536%203,collaborating%20physician%20or%20podiatric%20physician
• https://rxagent.co/blog/np-prescribing-authority#:~:text=However%2C%20,3
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care